Angiodynamics Stock Price Prediction
As of today the relative strength index (rsi) of AngioDynamics' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of AngioDynamics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with AngioDynamics, which may create opportunities for some arbitrage if properly timed.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using AngioDynamics hype-based prediction, you can estimate the value of AngioDynamics from the perspective of AngioDynamics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in AngioDynamics to buy its stock at a price that has no basis in reality. In that case, they are not buying AngioDynamics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AngioDynamics after-hype prediction price | USD 12.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AngioDynamics | Build AI portfolio with AngioDynamics Stock |
| Symbol | ANGO |
| Name | AngioDynamics |
| Type | Stock |
| Country | United States |
| Exchange | NASDAQ |
Hype Analysis is not found for AngioDynamics at this timeWe are unable to locate AngioDynamics hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.Hype Analysis
Prediction analysis is currently not available
Other Suggestions
Thematic Opportunities
Explore Investment Opportunities
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
AngioDynamics Additional Predictive Modules
Most predictive techniques to examine AngioDynamics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AngioDynamics using various technical indicators. When you analyze AngioDynamics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AngioDynamics Predictive Indicators
The successful prediction of AngioDynamics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AngioDynamics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AngioDynamics based on analysis of AngioDynamics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AngioDynamics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AngioDynamics's related companies.
Story Coverage note for AngioDynamics
The number of cover stories for AngioDynamics depends on current market conditions and AngioDynamics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AngioDynamics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AngioDynamics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
AngioDynamics Short Properties
AngioDynamics' future price predictability will typically decrease when AngioDynamics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AngioDynamics often depends not only on the future outlook of the potential AngioDynamics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AngioDynamics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41 M | |
| Cash And Short Term Investments | 55.9 M |
Check out AngioDynamics Basic Forecasting Models to cross-verify your projections. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.